Catalyst Pharmaceuticals ...

NASDAQ: CPRX · Real-Time Price · USD
20.23
0.16 (0.80%)
At close: Aug 15, 2025, 3:59 PM

Catalyst Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
517.55M 137.64M 298.39M 171.44M
Short-Term Investments
n/a n/a n/a 19.82M
Long-Term Investments
21.56M 16.49M n/a n/a
Other Long-Term Assets
n/a n/a 9K 9K
Receivables
65.48M 53.51M 10.44M 6.62M
Inventory
19.54M 15.64M 6.8M 7.87M
Other Current Assets
1.04M 489K 931K 432K
Total Current Assets
623.61M 219.33M 320.8M 210.11M
Property-Plant & Equipment
3.58M 3.7M 3.62M 3.98M
Goodwill & Intangibles
156.67M 194.05M 32.47M n/a
Total Long-Term Assets
227.8M 250.78M 54.83M 27.68M
Total Assets
851.41M 470.11M 375.63M 237.79M
Account Payables
16.59M 14.79M 3.98M 2.77M
Deferred Revenue
n/a n/a n/a 23.74M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
103.19M 51.29M 39.44M 19.87M
Total Current Liabilities
120.68M 76.06M 57.59M 27.06M
Long-Term Debt
n/a n/a 3.56M 3.89M
Other Long-Term Liabilities
315K 2.98M 10.51M -3.89M
Total Long-Term Liabilities
3.1M 6.17M 17.62M 3.89M
Total Liabilities
123.78M 82.23M 75.21M 30.96M
Total Debt
3.19M 3.56M 3.89M 3.89M
Common Stock
121K 107K 105K 103K
Retained Earnings
285.16M 121.27M 49.86M -26.31M
Comprehensive Income
64K 14K 24K -148K
Shareholders Equity
727.63M 387.88M 300.42M 206.83M
Total Investments
21.56M 16.49M n/a 19.82M